IBA invests in HIL Applied Medical Ltd to develop laser-based proton therapy system Potential of new technology to further reduce cost and size of proton therapy systems Louvain-la-Neuve, Belgium and Jerusalem, Israel, August 23, 2016 – IBA (Ion Beam Applications …
Continue reading »Dr. Jesse Adams joins HIL as VP, North America Dr. Adams joined HIL following the acquisition of NanoLabz, where he was Co-Founder and Vice President; there he led the development and fabrication of smart nano-engineered targets for the short-pulse laser …
Continue reading »Prof. Yehoshua (Shuki) Shemer joins HIL’s Board of Directors Professor Shemer is Chairman of the Board of Assuta Israel, the country’s largest private hospital network. He is also Director of the Israeli Center for Technology Assessment in Health Care (ICTAHC) …
Continue reading »Jerusalem Day interview: Jon Medved hosts Sagi Brink-Danan, CEO of HIL Applied Medical In honor of Jerusalem Day (June 5th, 2016), OurCrowd CEO Jonathan Medved interviews Sagi Brink-Danan, CEO of HIL Applied Medical, about the city’s startup ecosystem, growing high-tech …
Continue reading »Israeli startup HIL Applied Medical Ltd. acquires US-Based Nanolabz Inc. – en route to developing advanced cancer radiotherapy systems Jerusalem, Israel and Reno, Nevada. May 26, 2016 – HIL Applied Medical Ltd. – a Jerusalem, Israel medical technology startup – has …
Continue reading »HIL’s CEO to present at the annual OurCrowd Global Investor Summit The 2nd Annual OurCrowd Global Investor Summit will take place at the ICC – Israeli Convention Center (Binyanei Ha’Umah) – in Jerusalem, January 25-26th, 2016. Among many other exciting things it …
Continue reading »HIL granted US patent The USPTO today granted HIL another patent in the field of laser-based particle acceleration. This latest US patent – No. 9,236,215 – joins HIL’s growing international portfolio, and further protects various aspects of its technology. HIL has …
Continue reading »HIL ultra-compact system design presented at the 12th International Meeting on the Nuclear Applications of Accelerators. AccApp’15 – the 12th International Topical Meeting on the Nuclear Applications of Accelerators – is taking place today through Nov 13th in Washington, DC. HIL’s …
Continue reading »Dr. Raphael Pfeffer joins HIL’s Advisory Board Dr. Pfeffer is Chief of Oncology Division at Assuta Medical Centers – the largest and leading private medical services group in Israel – and a senior lecturer at the Tel-Aviv University School of …
Continue reading »Boaz Weinfeld joins HIL as Director of Development Boaz is a seasoned physicist and technology leader, with experience in both established companies and startup environments. Prior to joining HIL he was the CTO and Head of R&D of Novatrans, where …
Continue reading »